{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T20:03:25Z","timestamp":1793217805562,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Project of Postgraduate Education Innovation of Shanxi Province","award":["2022Y734"],"award-info":[{"award-number":["2022Y734"]}]},{"name":"Fundamental Research Program of Shanxi Province","award":["202403021221210"],"award-info":[{"award-number":["202403021221210"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-36923-2","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:54:21Z","timestamp":1768956861000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["An online interpretable machine learning model for predicting cardiometabolic multimorbidity risk in patients with type 2 diabetes mellitus"],"prefix":"10.1038","volume":"16","author":[{"given":"Xiaohan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotong","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"36923_CR1","doi-asserted-by":"crossref","unstructured":"Eilat-Tsanani, S., Margalit, A. & Golan, L. N. Occurrence of comorbidities in newly diagnosed type 2 diabetes patients and their impact after 11 years\u2019 follow-up. Sci. Rep. 11, 11071 (2021).","DOI":"10.1038\/s41598-021-90379-0"},{"key":"36923_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12916-019-1373-y","volume":"17","author":"M Nowakowska","year":"2019","unstructured":"Nowakowska, M. et al. The comorbidity burden of type 2 diabetes mellitus: patterns, clusters and predictions from a large english primary care cohort. BMC Med. 17, 145 (2019).","journal-title":"BMC Med."},{"key":"36923_CR3","unstructured":"Association of cardiorespiratory fitness. with the incidence and progression trajectory of cardiometabolic multimorbidity - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/39694627\/"},{"key":"36923_CR4","doi-asserted-by":"crossref","unstructured":"Hamo, C. E. et al. Cardiometabolic co-morbidity burden and circulating biomarkers in patients with chronic coronary disease in the ISCHEMIA trials. Am. J. Cardiol. 225, 118\u2013124 (2024).","DOI":"10.1016\/j.amjcard.2024.05.033"},{"key":"36923_CR5","first-page":"12","volume-title":"IDF DIABETES ATLAS","author":"DJ Magliano","year":"2021","unstructured":"Kumar, A., Gangwar, R., Zargar, A. A., Kumar, R. & Sharma, A. Prevalence of diabetes in India: A review of IDF diabetes atlas 10th edition. Curr. Diabetes Rev. 20, e130423215752 (2024)."},{"key":"36923_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12933-018-0722-z","volume":"17","author":"XD Zhuang","year":"2018","unstructured":"Zhuang, X. D. et al. Comparative cardiovascular outcomes in the era of novel anti-diabetic agents: a comprehensive network meta-analysis of 166,371 participants from 170 randomized controlled trials. Cardiovasc. Diabetol. 17, 79 (2018).","journal-title":"Cardiovasc. Diabetol."},{"key":"36923_CR7","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1007\/s13300-021-01060-8","volume":"12","author":"E Artime","year":"2021","unstructured":"Artime, E., Romera, I., D\u00edaz-Cerezo, S. & Delgado, E. Epidemiology and economic burden of cardiovascular disease in patients with type 2 diabetes mellitus in spain: A systematic review. Diabetes Ther. 12, 1631\u20131659 (2021).","journal-title":"Diabetes Ther."},{"key":"36923_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1001\/jama.2018.18269","volume":"321","author":"J Rosenstock","year":"2019","unstructured":"Rosenstock, J. et al. Effect of linagliptin vs placebo on major cardiovascular events in adults with type 2 diabetes and high cardiovascular and renal risk: the CARMELINA randomized clinical trial. JAMA 321, 69\u201379 (2019).","journal-title":"JAMA"},{"key":"36923_CR9","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.jval.2017.12.019","volume":"21","author":"TR Einarson","year":"2018","unstructured":"Einarson, T. R., Acs, A., Ludwig, C. & Panton, U. H. Economic burden of cardiovascular disease in type 2 diabetes: A systematic review. Value Health. 21, 881\u2013890 (2018).","journal-title":"Value Health"},{"key":"36923_CR10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4158\/CS-2019-0472","volume":"26","author":"AJ Garber","year":"2020","unstructured":"Garber, A. J. et al. Consensus statement by the American association of clinical endocrinologists and American college of endocrinology on the comprehensive type 2 diabetes management Algorithm \u2013 2020 executive summary. Endocr. Pract. 26, 107\u2013139 (2020).","journal-title":"Endocr. Pract."},{"key":"36923_CR11","doi-asserted-by":"publisher","first-page":"929","DOI":"10.3390\/diagnostics13050929","volume":"13","author":"CE Kosmas","year":"2023","unstructured":"Kosmas, C. E. et al. The Triglyceride\/High-Density lipoprotein cholesterol (TG\/HDL-C) ratio as a risk marker for metabolic syndrome and cardiovascular disease. Diagnostics (Basel). 13, 929 (2023).","journal-title":"Diagnostics (Basel)"},{"key":"36923_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2147\/NSS.S449862","volume":"16","author":"D Wang","year":"2024","unstructured":"Wang, D. et al. Application value of cardiometabolic index for the screening of obstructive sleep apnea with or without metabolic syndrome. Nat. Sci. Sleep. 16, 177\u2013191 (2024).","journal-title":"Nat. Sci. Sleep."},{"key":"36923_CR13","doi-asserted-by":"publisher","first-page":"e009754","DOI":"10.1161\/JAHA.118.009754","volume":"7","author":"MJ Gurka","year":"2018","unstructured":"Gurka, M. J., Filipp, S. L., Pearson, T. A. & DeBoer, M. D. Assessing baseline and Temporal changes in cardiometabolic risk using metabolic syndrome severity and common risk scores. J. Am. Heart Assoc. 7, e009754 (2018).","journal-title":"J. Am. Heart Assoc."},{"key":"36923_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12933-024-02564-w","volume":"24","author":"MG Syed","year":"2025","unstructured":"Syed, M. G. et al. Deep-learning prediction of cardiovascular outcomes from routine retinal images in individuals with type 2 diabetes. Cardiovasc. Diabetol. 24, 3 (2025).","journal-title":"Cardiovasc. Diabetol."},{"key":"36923_CR15","doi-asserted-by":"publisher","first-page":"110013","DOI":"10.1016\/j.diabres.2022.110013","volume":"190","author":"A Nicolucci","year":"2022","unstructured":"Nicolucci, A. et al. Prediction of complications of type 2 diabetes: A machine learning approach. Diabetes Res. Clin. Pract. 190, 110013 (2022).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"36923_CR16","unstructured":"Predicting cardiovascular disease among diabetic patients. in Ethiopia using machine learning models: evidence from Ethiopian public health Institute data (2024\/2025) - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/41286785\/"},{"key":"36923_CR17","doi-asserted-by":"crossref","unstructured":"Designing interpretable ML system to enhance trust in healthcare: A systematic review to proposed responsible clinician-AI-collaboration framework. Information Fusion 108, 102412 (2024).","DOI":"10.1016\/j.inffus.2024.102412"},{"key":"36923_CR18","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s10038-024-01231-y","volume":"69","author":"A Sharma","year":"2024","unstructured":"Sharma, A., Lysenko, A., Jia, S., Boroevich, K. A. & Tsunoda, T. Advances in AI and machine learning for predictive medicine. J. Hum. Genet. 69, 487\u2013497 (2024).","journal-title":"J. Hum. Genet."},{"key":"36923_CR19","doi-asserted-by":"publisher","first-page":"101924","DOI":"10.1016\/j.xcrm.2024.101924","volume":"6","author":"H Zhang","year":"2025","unstructured":"Zhang, H. et al. Multimodal integration using a machine learning approach facilitates risk stratification in HR+\/HER2- breast cancer. Cell. Rep. Med. 6, 101924 (2025).","journal-title":"Cell. Rep. Med."},{"key":"36923_CR20","doi-asserted-by":"publisher","first-page":"102721","DOI":"10.1016\/j.inffus.2024.102721","volume":"115","author":"B Xu","year":"2025","unstructured":"Xu, B. & Yang, G. Interpretability research of deep learning: A literature survey. Inform. Fusion. 115, 102721 (2025).","journal-title":"Inform. Fusion"},{"key":"36923_CR21","doi-asserted-by":"crossref","unstructured":"Wu, W., Guo, Y., Mo, Y., Jia, C. & Tietge, U. J. F. Interpretable machine learning model for predicting long-term cardiovascular mortality risk in chronic kidney disease patients using SHAP explainers. Eur. Heart J. 45, Supplement_1 (2024).","DOI":"10.1093\/eurheartj\/ehae666.3253"},{"key":"36923_CR22","doi-asserted-by":"publisher","first-page":"100479","DOI":"10.1016\/j.ese.2024.100479","volume":"22","author":"H Xu","year":"2024","unstructured":"Xu, H. et al. Trusted artificial intelligence for environmental assessments: an explainable high-precision model with multi-source big data. Environ. Sci. Ecotechnol. 22, 100479 (2024).","journal-title":"Environ. Sci. Ecotechnol"},{"key":"36923_CR23","doi-asserted-by":"publisher","first-page":"107161","DOI":"10.1016\/j.cmpb.2022.107161","volume":"226","author":"HW Loh","year":"2022","unstructured":"Loh, H. W. et al. Application of explainable artificial intelligence for healthcare: A systematic review of the last decade (2011\u20132022). Comput. Methods Programs Biomed. 226, 107161 (2022).","journal-title":"Comput. Methods Programs Biomed."},{"key":"36923_CR24","doi-asserted-by":"publisher","first-page":"107555","DOI":"10.1016\/j.compbiomed.2023.107555","volume":"166","author":"S Ali","year":"2023","unstructured":"Ali, S. et al. The enlightening role of explainable artificial intelligence in medical & healthcare domains: A systematic literature review. Comput. Biol. Med. 166, 107555 (2023).","journal-title":"Comput. Biol. Med."},{"key":"36923_CR25","unstructured":"Integrated statistical modeling. and machine learning techniques with SHAP for epidemiological data analysis - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/40578712\/"},{"key":"36923_CR26","doi-asserted-by":"publisher","first-page":"109569","DOI":"10.1016\/j.compbiomed.2024.109569","volume":"185","author":"SU Hassan","year":"2025","unstructured":"Hassan, S. U., Abdulkadir, S. J., Zahid, M. S. M. & Al-Selwi, S. M. Local interpretable model-agnostic explanation approach for medical imaging analysis: A systematic literature review. Comput. Biol. Med. 185, 109569 (2025).","journal-title":"Comput. Biol. Med."},{"key":"36923_CR27","doi-asserted-by":"publisher","first-page":"17728","DOI":"10.1038\/s41598-024-67844-7","volume":"14","author":"H Luo","year":"2024","unstructured":"Luo, H. et al. SHAP based predictive modeling for 1 year all-cause readmission risk in elderly heart failure patients: feature selection and model interpretation. Sci. Rep. 14, 17728 (2024).","journal-title":"Sci. Rep."},{"key":"36923_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40708-024-00222-1","volume":"11","author":"V Vimbi","year":"2024","unstructured":"Vimbi, V., Shaffi, N. & Mahmud, M. Interpreting artificial intelligence models: a systematic review on the application of LIME and SHAP in alzheimer\u2019s disease detection. Brain Inf. 11, 10 (2024).","journal-title":"Brain Inf."},{"key":"36923_CR29","doi-asserted-by":"publisher","first-page":"e70056","DOI":"10.1111\/cts.70056","volume":"17","author":"AV Ponce-Bobadilla","year":"2024","unstructured":"Ponce-Bobadilla, A. V., Schmitt, V., Maier, C. S., Mensing, S. & Stodtmann, S. Practical guide to SHAP analysis: explaining supervised machine learning model predictions in drug development. Clin. Transl Sci. 17, e70056 (2024).","journal-title":"Clin. Transl Sci."},{"key":"36923_CR30","doi-asserted-by":"crossref","unstructured":"Chowdhury, M. N. H. et al. Deep learning for early detection of chronic kidney disease stages in diabetes patients: A TabNet approach. Artif. Intell. Med. 166, 103153 (2025).","DOI":"10.1016\/j.artmed.2025.103153"},{"key":"36923_CR31","unstructured":"Framingham score adapted. a valid alternative for estimating cardiovascular risk in epidemiological studies - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/40089656\/"},{"key":"36923_CR32","unstructured":"Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/28536104\/"},{"key":"36923_CR33","doi-asserted-by":"crossref","unstructured":"Sim, R. et al. Comparison of a chronic kidney disease predictive model for type 2 diabetes mellitus in malaysia using cox regression versus machine learning approach. Clin. Kidney J. 16, 549\u2013559 (2023).","DOI":"10.1093\/ckj\/sfac252"},{"key":"36923_CR34","doi-asserted-by":"crossref","unstructured":"Dai, Y. et al. Remnant cholesterol for diabetic kidney disease risk stratification in type 2 diabetes: A machine learning-based prevention tool. Front. Nutr. 12, 1697943 (2025).","DOI":"10.3389\/fnut.2025.1697943"},{"key":"36923_CR35","doi-asserted-by":"publisher","first-page":"123514","DOI":"10.1016\/j.watres.2025.123514","volume":"280","author":"Y Takefuji","year":"2025","unstructured":"Takefuji, Y. Reevaluating feature importance in machine learning: concerns regarding SHAP interpretations in the context of the EU artificial intelligence act. Water Res. 280, 123514 (2025).","journal-title":"Water Res."},{"key":"36923_CR36","unstructured":"Artificial Intelligence for Diabetes Complication Prediction. A Systematic Review of Current Applications and Future Directions - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/41317170\/"},{"key":"36923_CR37","unstructured":"Integrated image-based. deep learning and language models for primary diabetes care - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/39030266\/"},{"key":"36923_CR38","unstructured":"Correction & ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease. : Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines - PubMed. (2019). https:\/\/pubmed.ncbi.nlm.nih.gov\/32310698\/"},{"key":"36923_CR39","unstructured":"Correction to: Guidelines for the Early Management of Patients With Acute Ischemic Stroke. : 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association\/American Stroke Association - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/31765293\/"},{"issue":"7","key":"36923_CR40","first-page":"603","volume":"32","author":"Chinese Hypertension League Prevention and Treatment Guidelines Revision Committee","year":"2024","unstructured":"Chinese Hypertension League Prevention and Treatment Guidelines Revision Committee. Chinese guidelines for the prevention and treatment of hypertension (2024 Revision). Chin. J. Hypertens. (Chinese English). 32 (7), 603\u2013700 (2024).","journal-title":"Chin. J. Hypertens. (Chinese English)"},{"key":"36923_CR41","unstructured":"Calculating the sample. size required for developing a clinical prediction model - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/32188600\/"},{"key":"36923_CR42","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1111\/dom.14323","volume":"23","author":"J Ling","year":"2021","unstructured":"Ling, J. et al. Temporal trends in co-morbidities and cardiometabolic risk factors at the time of type 2 diabetes diagnosis in the UK. Diabetes Obes. Metab. 23, 1150\u20131161 (2021).","journal-title":"Diabetes Obes. Metab."},{"key":"36923_CR43","doi-asserted-by":"publisher","first-page":"383","DOI":"10.4239\/wjd.v12.i4.383","volume":"12","author":"J Rajbhandari","year":"2021","unstructured":"Rajbhandari, J., Fernandez, C. J., Agarwal, M., Yeap, B. X. Y. & Pappachan, J. M. Diabetic heart disease: A clinical update. World J. Diabetes. 12, 383\u2013406 (2021).","journal-title":"World J. Diabetes"},{"key":"36923_CR44","doi-asserted-by":"publisher","first-page":"105090","DOI":"10.1016\/j.ijmedinf.2023.105090","volume":"175","author":"R Kablan","year":"2023","unstructured":"Kablan, R., Miller, H. A., Suliman, S. & Frieboes, H. B. Evaluation of stacked ensemble model performance to predict clinical outcomes: A COVID-19 study. Int. J. Med. Inf. 175, 105090 (2023).","journal-title":"Int. J. Med. Inf."},{"key":"36923_CR45","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12864-019-6413-7","volume":"21","author":"D Chicco","year":"2020","unstructured":"Chicco, D. & Jurman, G. The advantages of the Matthews correlation coefficient (MCC) over F1 score and accuracy in binary classification evaluation. BMC Genom. 21, 6 (2020).","journal-title":"BMC Genom."},{"key":"36923_CR46","doi-asserted-by":"publisher","first-page":"103407","DOI":"10.1016\/j.ebiom.2021.103407","volume":"68","author":"S Gitto","year":"2021","unstructured":"Gitto, S. et al. CT radiomics-based machine learning classification of atypical cartilaginous tumours and appendicular chondrosarcomas. EBioMedicine 68, 103407 (2021).","journal-title":"EBioMedicine"},{"key":"36923_CR47","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.35833\/MPCE.2023.000909","volume":"12","author":"L Ge","year":"2024","unstructured":"Ge, L. et al. A fault diagnosis method for smart meters via Two-Layer stacking ensemble optimization and data augmentation. J. Mod. Power Syst. Clean. Energy. 12, 1272\u20131284 (2024).","journal-title":"J. Mod. Power Syst. Clean. Energy"},{"key":"36923_CR48","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12933-022-01516-6","volume":"21","author":"CX Ma","year":"2022","unstructured":"Ma, C. X. et al. Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management. Cardiovasc. Diabetol. 21, 74 (2022).","journal-title":"Cardiovasc. Diabetol."},{"key":"36923_CR49","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13098-023-01015-y","volume":"15","author":"X Jiao","year":"2023","unstructured":"Jiao, X., Zhang, Q., Peng, P. & Shen, Y. HbA1c is a predictive factor of severe coronary stenosis and major adverse cardiovascular events in patients with both type 2 diabetes and coronary heart disease. Diabetol. Metab. Syndr. 15, 50 (2023).","journal-title":"Diabetol. Metab. Syndr."},{"key":"36923_CR50","doi-asserted-by":"publisher","first-page":"1131395","DOI":"10.3389\/fendo.2023.1131395","volume":"14","author":"X Yao","year":"2023","unstructured":"Yao, X. et al. Age at diagnosis, diabetes duration and the risk of cardiovascular disease in patients with diabetes mellitus: a cross-sectional study. Front. Endocrinol. (Lausanne). 14, 1131395 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"36923_CR51","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1161\/ATVBAHA.116.306256","volume":"37","author":"K Yahagi","year":"2017","unstructured":"Yahagi, K. et al. Pathology of human coronary and carotid artery atherosclerosis and vascular calcification in diabetes mellitus. Arterioscler. Thromb. Vasc Biol. 37, 191\u2013204 (2017).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"36923_CR52","unstructured":"Duration of Diabetes and Prediabetes During Adulthood and Subclinical Atherosclerosis. and Cardiac Dysfunction in Middle Age: The CARDIA Study - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/29317451\/"},{"key":"36923_CR53","doi-asserted-by":"publisher","first-page":"109899","DOI":"10.1016\/j.diabres.2022.109899","volume":"188","author":"M de Jong","year":"2022","unstructured":"de Jong, M., Woodward, M. & Peters, S. A. E. Duration of diabetes and the risk of major cardiovascular events in women and men: A prospective cohort study of UK biobank participants. Diabetes Res. Clin. Pract. 188, 109899 (2022).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"36923_CR54","doi-asserted-by":"crossref","unstructured":"Yang, J. et al. The impact of the triglyceride-glucose index on poor prognosis in NonDiabetic patients undergoing percutaneous coronary intervention. Front. Endocrinol. (Lausanne) 12, 710240 (2021).","DOI":"10.3389\/fendo.2021.710240"},{"key":"36923_CR55","doi-asserted-by":"crossref","unstructured":"K, R. et al. Association Between the Metabolic Score for Insulin Resistance and Hypertension in Adults: A Meta-Analysis. Hormone and metabolic research\u2009=\u2009Hormon- und Stoffwechselforschung\u2009=\u2009Hormones et metabolisme 55, (2023).","DOI":"10.1055\/a-2010-2452"},{"key":"36923_CR56","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.2147\/DMSO.S404878","volume":"16","author":"X Zhang","year":"2023","unstructured":"Zhang, X. et al. Metabolic score for insulin resistance (METS-IR) predicts adverse cardiovascular events in patients with type 2 diabetes and ischemic cardiomyopathy. Diabetes Metab. Syndr. Obes. 16, 1283\u20131295 (2023).","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"36923_CR57","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12933-023-01898-1","volume":"22","author":"Z Zhang","year":"2023","unstructured":"Zhang, Z., Zhao, L., Lu, Y., Meng, X. & Zhou, X. Association between non-insulin-based insulin resistance indices and cardiovascular events in patients undergoing percutaneous coronary intervention: a retrospective study. Cardiovasc. Diabetol. 22, 161 (2023).","journal-title":"Cardiovasc. Diabetol."},{"key":"36923_CR58","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1093\/eurpub\/ckac140","volume":"32","author":"C Xu","year":"2022","unstructured":"Xu, C. et al. Association of METS-IR with incident hypertension in non-overweight adults based on a cohort study in Northeastern China. Eur. J. Public. Health. 32, 884\u2013890 (2022).","journal-title":"Eur. J. Public. Health"},{"key":"36923_CR59","doi-asserted-by":"publisher","first-page":"918359","DOI":"10.3389\/fcvm.2022.918359","volume":"9","author":"Z Wu","year":"2022","unstructured":"Wu, Z. et al. Comparison of three non-insulin-based insulin resistance indexes in predicting the presence and severity of coronary artery disease. Front. Cardiovasc. Med. 9, 918359 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"36923_CR60","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s12933-023-02073-2","volume":"22","author":"X Tian","year":"2023","unstructured":"Tian, X. et al. Magnitude and time course of insulin resistance accumulation with the risk of cardiovascular disease: an 11-years cohort study. Cardiovasc. Diabetol. 22, 339 (2023).","journal-title":"Cardiovasc. Diabetol."},{"key":"36923_CR61","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1055\/s-0039-1694969","volume":"119","author":"G Patti","year":"2019","unstructured":"Patti, G. et al. Platelet indices and risk of death and cardiovascular events: results from a large Population-Based cohort study. Thromb. Haemost. 119, 1773\u20131784 (2019).","journal-title":"Thromb. Haemost"},{"key":"36923_CR62","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.2147\/DMSO.S425469","volume":"16","author":"A Kelem","year":"2023","unstructured":"Kelem, A., Adane, T. & Shiferaw, E. Insulin Resistance-Induced platelet hyperactivity and a potential biomarker role of platelet parameters: A narrative review. Diabetes Metab. Syndr. Obes. 16, 2843\u20132853 (2023).","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"36923_CR63","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3390\/antiox10050706","volume":"10","author":"AR Vaidya","year":"2021","unstructured":"Vaidya, A. R. et al. Diabetes and thrombosis: A central role for vascular oxidative stress. Antioxid. (Basel). 10, 706 (2021).","journal-title":"Antioxid. (Basel)"},{"key":"36923_CR64","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3390\/cells9030567","volume":"9","author":"H El Hadi","year":"2020","unstructured":"El Hadi, H., Di Vincenzo, A., Vettor, R. & Rossato, M. Relationship between heart disease and liver disease: A Two-Way street. Cells 9, 567 (2020).","journal-title":"Cells"},{"key":"36923_CR65","doi-asserted-by":"publisher","first-page":"9649","DOI":"10.1038\/s41598-025-93184-1","volume":"15","author":"Q Li","year":"2025","unstructured":"Li, Q. & Lan, W. Association between De-Ritis ratio (AST\/ALT) and mortality in patients with chronic kidney disease: a retrospective cohort study. Sci. Rep. 15, 9649 (2025).","journal-title":"Sci. Rep."},{"key":"36923_CR66","doi-asserted-by":"publisher","first-page":"26317","DOI":"10.1038\/s41598-024-77141-y","volume":"14","author":"Y Bian","year":"2024","unstructured":"Bian, Y. et al. Association between aspartate aminotransferase to Alanine aminotransferase ratio and mortality in critically ill patients with congestive heart failure. Sci. Rep. 14, 26317 (2024).","journal-title":"Sci. Rep."},{"key":"36923_CR67","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.2337\/dc24-1375","volume":"47","author":"R Retnakaran","year":"2024","unstructured":"Retnakaran, R. et al. A glycemic threshold above which the improvement of \u03b2-Cell function and glycemia in response to insulin therapy is amplified in early type 2 diabetes: the reversal of glucotoxicity. Diabetes Care. 47, 2017\u20132023 (2024).","journal-title":"Diabetes Care"},{"key":"36923_CR68","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41569-023-00877-z","volume":"20","author":"ND Wong","year":"2023","unstructured":"Wong, N. D. & Sattar, N. Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention. Nat. Rev. Cardiol. 20, 685\u2013695 (2023).","journal-title":"Nat. Rev. Cardiol."},{"key":"36923_CR69","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12933-023-01876-7","volume":"22","author":"J Zheng","year":"2023","unstructured":"Zheng, J. et al. Normal-weight visceral obesity promotes a higher 10-year atherosclerotic cardiovascular disease risk in patients with type 2 diabetes mellitus-a multicenter study in China. Cardiovasc. Diabetol. 22, 137 (2023).","journal-title":"Cardiovasc. Diabetol."},{"key":"36923_CR70","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2215\/CJN.08210815","volume":"11","author":"K Kajimoto","year":"2016","unstructured":"Kajimoto, K., Sato, N. & Takano, T. eGFR and outcomes in patients with acute decompensated heart failure with or without elevated BUN. Clin. J. Am. Soc. Nephrol. 11, 405\u2013412 (2016).","journal-title":"Clin. J. Am. Soc. Nephrol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36923-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36923-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36923-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T11:04:37Z","timestamp":1770807877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36923-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["36923"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-36923-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"24 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted according to the ethical standards of the institutional or national research committee and the 1964\n                      Helsinki Declaration\n                      and approved by the Ethics Committee of Changzhi Medical College (Approval date: 2023-10-12, approval number: RT2023045). And informed consent was obtained from all participants in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"5877"}}